BACKGROUND: Genetic background has a profound effect on inflammatory bowel disease. The Gpx1 and Gpx2 double knockout (GPX1/2-DKO) mice on a mixed C57BL/6 (B6) and 129S1/SvimJ (129) background exhibit spontaneous ileocolitis. The DKO mice on a B6 background have mild ileocolitis. We characterized the 129 DKO mice to identify a genetic locus affecting disease severity. METHODS: We backcrossed B6;129 DKO mice to 129 and analyzed for ileocolitis penetrance and severity at N5, N7, and N10. By correlating disease severity with single-nucleotide polymorphism (SNP) markers, we identified a colitis locus. RESULTS: As early as 9 days of age, 129 DKO N5 and N10 mice showed disease signs and morbidity. The N10 DKO mice had the severest colitis with nearly complete penetrance and high morbidity compared with other generations or backgrounds. 129 DKO mice had elevated colonic KC and SAA3 expression, shorter colon length, and cecal E. coli overgrowth compared to B6 DKO mice. Analysis of the B6 loci in 129 N5, N7, and N10 cohorts pointed to a region of chromosome 2: 119 Mbp contributing to mild symptoms. CONCLUSIONS: GPX1/2-DKO mice on 129 genetic background have the most aggressive colitis compared to B6;129 and B6 colonies. A B6 locus significantly contributing the resistance resides on chromosome 2: 119 Mbp. This region coincides with cytokine-deficiency-induced colitis susceptibility, Cdcs3, identified in the resistant B6 and sensitive C3H/HeJBir (C3Bir) with IL-10 deficiency. A three-way SNP analysis between 129, B6, and C3Bir locus points the major candidate genes to B2m, Dnajc17, Duox2, Pla2g4b, Pla2g4e, Pla2g4f and Slc30a4.
BACKGROUND: Genetic background has a profound effect on inflammatory bowel disease. The Gpx1 and Gpx2 double knockout (GPX1/2-DKO) mice on a mixed C57BL/6 (B6) and 129S1/SvimJ (129) background exhibit spontaneous ileocolitis. The DKO mice on a B6 background have mild ileocolitis. We characterized the 129 DKO mice to identify a genetic locus affecting disease severity. METHODS: We backcrossed B6;129 DKO mice to 129 and analyzed for ileocolitis penetrance and severity at N5, N7, and N10. By correlating disease severity with single-nucleotide polymorphism (SNP) markers, we identified a colitis locus. RESULTS: As early as 9 days of age, 129 DKO N5 and N10mice showed disease signs and morbidity. The N10 DKO mice had the severest colitis with nearly complete penetrance and high morbidity compared with other generations or backgrounds. 129 DKO mice had elevated colonic KC and SAA3 expression, shorter colon length, and cecal E. coli overgrowth compared to B6 DKO mice. Analysis of the B6 loci in 129 N5, N7, and N10 cohorts pointed to a region of chromosome 2: 119 Mbp contributing to mild symptoms. CONCLUSIONS:GPX1/2-DKO mice on 129 genetic background have the most aggressive colitis compared to B6;129 and B6 colonies. A B6 locus significantly contributing the resistance resides on chromosome 2: 119 Mbp. This region coincides with cytokine-deficiency-induced colitis susceptibility, Cdcs3, identified in the resistant B6 and sensitive C3H/HeJBir (C3Bir) with IL-10 deficiency. A three-way SNP analysis between 129, B6, and C3Bir locus points the major candidate genes to B2m, Dnajc17, Duox2, Pla2g4b, Pla2g4e, Pla2g4f and Slc30a4.
Authors: Young-Kyu Park; Jeffrey L Franklin; Stephen H Settle; Shawn E Levy; Eunkyung Chung; Loice H Jeyakumar; Yu Shyr; Mary Kay Washington; Robert H Whitehead; Bruce J Aronow; Robert J Coffey Journal: Genesis Date: 2005-01 Impact factor: 2.487
Authors: T Tani; K Hanasawa; M Kodama; H Imaizumi; M Yonekawa; M Saito; T Ikeda; Y Yagi; K Takayama; I Amano; H Shimaoka; M Ohta; T Okahisa; N Koga; N Fujita; H Yamasa Journal: World J Surg Date: 2001-05 Impact factor: 3.352
Authors: I J Bristol; M A Farmer; Y Cong; X X Zheng; T B Strom; C O Elson; J P Sundberg; E H Leiter Journal: Inflamm Bowel Dis Date: 2000-11 Impact factor: 5.325
Authors: Maike F de Buhr; Michael Mähler; Robert Geffers; Wiebke Hansen; Astrid M Westendorf; Jörg Lauber; Jan Buer; Brigitte Schlegelberger; Hans J Hedrich; Andre Bleich Journal: Physiol Genomics Date: 2006-05-16 Impact factor: 3.107
Authors: Maren von Köckritz-Blickwede; Manfred Rohde; Sonja Oehmcke; Lloyd S Miller; Ambrose L Cheung; Heiko Herwald; Simon Foster; Eva Medina Journal: Am J Pathol Date: 2008-10-30 Impact factor: 4.307
Authors: Byung-Wook Kim; R Steven Esworthy; Maria A Hahn; Gerd P Pfeifer; Fong-Fong Chu Journal: Free Radic Biol Med Date: 2012-02-15 Impact factor: 7.376
Authors: R Steven Esworthy; Byung-Wook Kim; Yufeng Wang; Qiang Gao; James H Doroshow; Thomas L Leto; Fong-Fong Chu Journal: Free Radic Biol Med Date: 2013-10-01 Impact factor: 7.376
Authors: Robert S Esworthy; Byung-Wook Kim; Joni Chow; Binghui Shen; James H Doroshow; Fong-Fong Chu Journal: Free Radic Biol Med Date: 2013-12-25 Impact factor: 7.376
Authors: R Steven Esworthy; Byung-Wook Kim; Guillermo E Rivas; Thomas L Leto; James H Doroshow; Fong-Fong Chu Journal: PLoS One Date: 2012-09-06 Impact factor: 3.240
Authors: Allison R Rogala; Andrew P Morgan; Alexis M Christensen; Terry J Gooch; Timothy A Bell; Darla R Miller; Virginia L Godfrey; Fernando Pardo-Manuel de Villena Journal: Mamm Genome Date: 2014-02-01 Impact factor: 2.957
Authors: Fong-Fong Chu; R Steven Esworthy; James H Doroshow; Helmut Grasberger; Agnes Donko; Thomas L Leto; Qiang Gao; Binghui Shen Journal: Redox Biol Date: 2016-11-22 Impact factor: 11.799